**Question:** In Non-competitive inhibition of enzyme:

A. The inhibitor binds to the enzyme-substrate complex
B. The inhibitor binds to the active site of the enzyme
C. The inhibitor binds to the allosteric site of the enzyme
D. The inhibitor binds to a site on the enzyme that competes with the substrate

**Correct Answer:** C. The inhibitor binds to the allosteric site of the enzyme

**Core Concept:** Inhibition of enzymes is a pharmacological phenomenon that occurs when a molecule or compound, called an inhibitor, binds to an enzyme, resulting in a decrease in the enzyme's activity. There are two main types of enzyme inhibition: competitive and non-competitive inhibition.

**Why the Correct Answer is Right:** Non-competitive inhibition is a type of enzyme inhibition where the inhibitor binds to a specific site on the enzyme, known as the allosteric site, which is distinct from the active site where the substrate binds. This binding causes a conformational change in the enzyme structure, reducing its catalytic activity. Non-competitive inhibitors do not displace the substrate (substrate remains bound to the enzyme), but rather decrease the enzyme's affinity for the substrate.

**Why Each Wrong Option is Incorrect:**

A. In competitive inhibition, the inhibitor binds to the active site of the enzyme, competing with the substrate for binding. This option is incorrect because non-competitive inhibition involves binding to the allosteric site, not the active site.

B. This option is incorrect because the inhibitor in non-competitive inhibition binds to the allosteric site, not the active site where the substrate binds.

D. In competitive inhibition, the inhibitor competes with the substrate for binding to the active site, leading to reduced enzyme activity. This option is incorrect because it describes competitive inhibition, not non-competitive inhibition.

**Clinical Pearl:** Non-competitive inhibition is relevant in understanding drug interactions, particularly with enzymes involved in drug elimination. Understanding this type of inhibition helps predict the pharmacokinetic effects of drugs and tailor dosing regimens to maintain therapeutic levels while preventing adverse reactions due to drug inhibition.